<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01027988</url>
  </required_header>
  <id_info>
    <org_study_id>ICM 08-1050</org_study_id>
    <nct_id>NCT01027988</nct_id>
  </id_info>
  <brief_title>Retina Microvascularisation and Cardiovascular Heart Disease Prediction</brief_title>
  <official_title>Retina Microvascularisation and Cardiovascular Heart Disease Prediction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montreal Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonds de la Recherche en Santé du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Montreal Heart Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Earlier studies have found that retinal photography could be very useful for evaluating the&#xD;
      condition of microcirculation and the risk of cardiovascular diseases in patients. The&#xD;
      architectural changes in retinal vascularisation strongly correlates with macrovascular&#xD;
      remodeling. Also, recent founding suggests a possible close anatomical parallel between both&#xD;
      the macrovascular and the microvascular blood.&#xD;
&#xD;
      Our objectives are to assess (1) in which age and sex subgroups, if any, retinal vascular&#xD;
      alteration in arterioles and venules can be predictive for cardiovascular morbidity and&#xD;
      mortality; and (2) whether variations in arteriolar or venular caliber will predict better&#xD;
      cardiovascular pathogenesis in normal and patient population. If the association between the&#xD;
      diameter of the retinal vessels and the risks of cardiovascular disease is verified during&#xD;
      this study, the impact on prevention would be enormous. The retinal microvascular change&#xD;
      could become a powerful biomarker in the early detection of the cardiovascular pathogenesis&#xD;
      and death risk&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of a major cardiovascular event or complication, defined as hospitalization, death from coronary heart disease, hypertension, arteriosclerosis, nonfatal non-procedure-related myocardial infarction, or fatal or nonfatal stroke</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterization of any retinal vascular disorders occurring at any time during the study: i. Confirmed by an ophthalmologist examination and either an fundus camera or an mfERGs examination ii. Occurrence of serious ophthalmic event</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation with possible cardiovascular event</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Cardiovascular Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        (50 to 70 years old) with history of coronary heart disease (CHD) or one or more risk&#xD;
        factors.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 50 to 70 years old (male/female)&#xD;
&#xD;
          -  indication of coronarography within the last 3 month preceding the enrollment&#xD;
&#xD;
          -  Patients with history of stroke, heart failure or arteriosclerosis.&#xD;
&#xD;
          -  At least one of the following risk factors for cardiovascular complication:&#xD;
&#xD;
               -  Hypertension&#xD;
&#xD;
               -  Coronary heart disease (CHD)&#xD;
&#xD;
               -  Diabetes&#xD;
&#xD;
               -  Structural heart disease&#xD;
&#xD;
               -  Dyslipidemia&#xD;
&#xD;
               -  Obesity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a permanent pacemaker or ICD&#xD;
&#xD;
          -  Nephrosis or chronic renal failure&#xD;
&#xD;
          -  The study interferes with therapeutic or diagnostic procedures&#xD;
&#xD;
          -  Patients with inability to consent or comply with follow up requirements&#xD;
&#xD;
          -  Patients with glaucoma&#xD;
&#xD;
          -  Patients with any retina degeneration disease vascular age-related macular&#xD;
             degeneration or any -retina degeneration disease&#xD;
&#xD;
          -  Patients who are pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Thibault, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montreal Heart Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montreal Heart Institute, 5000 Belanger Street</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>HIT IC8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <study_first_submitted>December 7, 2009</study_first_submitted>
  <study_first_submitted_qc>December 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2009</study_first_posted>
  <last_update_submitted>October 29, 2013</last_update_submitted>
  <last_update_submitted_qc>October 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montreal Heart Institute</investigator_affiliation>
    <investigator_full_name>Bernard Thibault</investigator_full_name>
    <investigator_title>Cardiologist - Electrophysiologist</investigator_title>
  </responsible_party>
  <keyword>Retinal Microvascularisation</keyword>
  <keyword>Fundus</keyword>
  <keyword>mfERGs</keyword>
  <keyword>CHF</keyword>
  <keyword>Cardiovascular Disease</keyword>
  <keyword>Coronarography</keyword>
  <keyword>Macrovascularisation</keyword>
  <keyword>The objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

